Emulate

About

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Boston,Massachusetts,United States
51 - 100
http://emulatebio.com

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $27.99M
Industries: Biotechnology,Health Care,Life Science,Medical
Founded date: Jan 1, 2013
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Emulate Inc.

Emulate is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$224.26M

Emulate has raised a total of $224.26M in funding over 2 rounds. Their latest funding was raised on Sep 7, 2021 from a Series E round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 7, 2021	Series E	$82M	2	Northpond Ventures	—	Detail
Mar 6, 2020	Debt Financing	$19.27M	1	—	—	Detail
Mar 6, 2020	Series D	—	3	—	—	Detail
Aug 1, 2019	Series Unknown	$27.99M	1	Ethos Family Office	—	Detail
Jun 18, 2018	Series C	$36M	5	Founders Fund	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

19

Emulate is funded by 19 investors. Northpond Ventures and Ethos Family Office are the most recent investors.

Investor Name	Lead Investor	Funding Round
Northpond Ventures	Yes	Series E
Ethos Family Office	Yes	Series Unknown
National Institutes of Health	Yes	Grant
Perceptive Advisors	—	Series E
Alumni Ventures	—	Debt Financing
Founders Fund	—	Series D
ALS Investment Fund	—	Series C
Glass Wall Syndicate	—	Series C
SciFi VC	—	Series C
Starlight Ventures	—	Series C